Related Experiment Videos
[Concentration of myoglobin in serum in patients with heart transplantation]
W Pokrzywnicki1, W Grzeszczak, A Kochańska
1Kliniki Chorób Wewnetrznych i Zawodowych w Zabrzu.
Insights
Myoglobin levels did not significantly change in heart transplant patients (HTP) compared to healthy individuals. However, cyclosporine A, a medication used post-transplant, showed a nephrotoxic effect, reducing creatinine clearance.
Area of Science:
- Cardiology
- Nephrology
- Biochemistry
Context:
- Heart transplantation is a life-saving procedure for end-stage heart failure.
- Post-transplant management involves immunosuppressive drugs like cyclosporine A.
- Monitoring biochemical markers is crucial for assessing patient outcomes and drug toxicity.
Purpose:
- To investigate changes in myoglobin concentration in patients following heart transplantation.
- To evaluate the potential impact of heart transplantation on myoglobin levels.
- To assess the nephrotoxic effects of cyclosporine A in heart transplant recipients.
Summary:
- Myoglobin concentration was measured in 31 healthy controls and 15 heart transplant patients using the RIA method.
- No statistically significant differences in myoglobin concentration changes were observed between the heart transplant patient group and the control group.
- A decrease in creatinine clearance was confirmed in heart transplant patients, indicating a nephrotoxic effect of cyclosporine A.
Impact:
- This study highlights that myoglobin is not a sensitive marker for changes after heart transplantation.
- It confirms the known nephrotoxicity of cyclosporine A, emphasizing the need for careful renal function monitoring in transplant patients.
- Findings contribute to understanding the physiological changes and drug-related side effects in heart transplant recipients.
Abstract:
The studies were carried out, the aim of which was the answer to question what are the changes of myoglobin concentration in patients after heart transplantation. For this purpose, 31 healthy persons being the control group (C) and 15 patients after heart transplantation (HTP) were studied. In both groups myoglobin concentration was determined by the RIA method, finding no statistically significant differences in changes of this parameter between the two studied groups. However, the nephrotoxic effect was confirmed of cyclosporin A which was continuously taken by the patients after heart transplantation, expressed as the decrease of creatinine clearance.